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Abstract
Since the middle of the XXth century, Fourier transform infrared (FT-IR) spectroscopy has been employed as a nondestructive,
label-free, highly sensitive, and specific analytical method with many potential applications in different fields of biomedical
research and in particular cancer research and diagnosis. In this study, infrared spectra of normal human bone and tumor tissue of
osteosarcoma were analyzed using FT-IR spectroscopy in the range of 800–1800 cm−1. The results revealed that some of the
spectral characteristics varied significantly between normal and malignant tissues, that is, IR peak positions, and the spectral
intensities. The main changes in the spectral features of tissues were observed in the phosphate ν1, ν3 contour (950–1200 cm−1)
and Amide I (1620–1680 cm−1) and II (1520–1570 cm−1) bands. The molecular interpretation of the differences between normal
and pathological states of bone tissues may indicate the changes in hydroxyapatite mineralization and collagen structure of the
malignant tissue. The most important application of this technique is evaluation of the disease states and the results of therapeutic
intervention under the medical treatment.
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1 Introduction
Cancer is biostructure disorders including uncontrolled cell divi-
sion, invasive cell growth into adjacent tissue, and metastatic
implantation to other body sites [1]. It is becoming the leading
cause of death around the world. Further developments in cancer
treatment as well as diagnostic methods are required. One of the
available techniques that can effectively provide information
concerning the structure and chemical composition of biological
materials in various human cancers at the molecular level in a
nondestructive and label-free manner is Fourier transform
infrared spectroscopy (FT-IR) [2]. The great advantage of FT-
IR spectroscopy is that any sample (a variety of human body
fluids, tissues, and calcified minerals) may be studied in virtually
any state and no specific reagents are required. The FT-IR wave-
number range from 4000 to 400 cm−1 includes the so-called bio-
fingerprint region (1800 to 900 cm−1), containing the fundamen-
tal vibrational modes of key chemical bonds that may provide a
nondestructive, screening approach for the detection, identifica-
tion, and characterization of the molecular components of bio-
logical processes in tissues [3]. Since molecular structure and
function are strongly correlated, changes of structure may be
used to elucidate a pathological status of tissue [2].
In the past three decades, FT-IR spectroscopic analysis has
become an essential tool for the detection, identification, and
characterization of the molecular components of biological pro-
cesses that is responsible for the dynamic properties of cancer
progression [4]. FT-IR spectroscopy has been successfully ap-
plied to study the different types of cancer including breast,
prostate, lung, cervical, colon, brain, skin, and liver tumors
[5–8]. Osteosarcoma is a malignant tumor characterized by
spindle cells of mesenchymal origin depositing immature oste-
oid matrix that primarily affects the long bones but can also
involve other bones in the body [9]. FT-IR spectroscopy has
been used since the 1960s to characterize the mineral and
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